文献速递消化内镜消化道肿瘤与早癌

内镜黏膜切除术与内镜黏膜下剥离术治疗巴雷特食管相关肿瘤及食管腺癌的比较:系统综述与Meta分析

Comparison of EMR versus endoscopic submucosal dissection for Barrett's neoplasia and esophageal adenocarcinoma: a systematic review and meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2024-06-13

该系统综述与Meta分析比较内镜黏膜切除术(EMR)与内镜黏膜下剥离术(ESD)治疗巴雷特食管相关肿瘤及食管腺癌的疗效,检索3个数据库至2023年10月,最终纳入11项研究。结果显示ESD的整块切除率、R0切除率显著更高,治愈性切除率有更高趋势,局部复发率有更低趋势,而异型增生完全缓解率及出血、穿孔、术后狭窄等不良事件无显著差异。作者认为ESD可能是更有效的选择。

要点

  • ESD整块切除率显著高于EMR(OR 31.53,95%CI 10.02-99.19,P<.01,7项研究)。
  • ESD的R0切除率显著高于EMR(OR 5.92,95%CI 2.75-12.77,P<.01,8项研究)。
  • 局部复发率ESD有更低趋势(OR 0.35,95%CI 0.11-1.04,P=.058,10项研究),出血、穿孔、术后狭窄无显著差异。

核心结论

  • 该系统综述与Meta分析表明,ESD的整块切除率、R0切除率和治愈性切除率更高,局部复发率有更低趋势。
  • 作者认为ESD可能是治疗巴雷特食管相关肿瘤及食管腺癌更有效的选择。

研究设计与样本

  • 系统综述与Meta分析,检索Embase、MEDLINE、Cochrane Central 3个数据库至2023年10月。
  • 纳入比较EMR与ESD治疗巴雷特食管相关肿瘤及食管腺癌疗效的研究。
  • 检索共发现905条记录,最终纳入11项研究进行分析。
  • PROSPERO注册号:CRD42023426486。

主要发现

  • 整块切除率ESD显著高于EMR(OR 31.53,95%CI 10.02-99.19,P<.01,7项研究)。
  • R0切除率ESD显著高于EMR(OR 5.92,95%CI 2.75-12.77,P<.01,8项研究)。
  • 治愈性切除率ESD有更高趋势(OR 3.49,95%CI 0.86-14.14,P=.080,4项研究)。
  • 异型增生完全缓解率(CRD)EMR与ESD无显著差异(OR 0.92,95%CI 0.37-2.26,P=.86,3项研究)。
  • 局部复发率ESD有更低趋势(OR 0.35,95%CI 0.11-1.04,P=.058,10项研究)。

临床怎么用

  • 作者认为ESD可能是治疗巴雷特食管相关肿瘤及食管腺癌更有效的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: EMR and endoscopic submucosal dissection (ESD) are both accepted resection strategies for Barrett's esophagus-related neoplasia and esophageal adenocarcinoma (EAC). However, a lack of consensus exists regarding which technique offers superior outcomes. This study aims to systematically review the evidence comparing EMR versus ESD in treating Barrett's neoplasia and EAC. METHODS: We searched 3 databases (Embase, MEDLINE, Cochrane Central) through October 2023. We included studies comparing the efficacy of EMR and ESD for Barrett's neoplasia and EAC. Primary outcomes include en bloc, R0, and curative resection; complete remission of dysplasia (CRD), and local recurrence. Secondary outcomes encompass adverse events. RESULTS: Our search identified 905 records. Eleven studies were included in the final analyses. Data showed significantly higher en bloc resection rates with ESD (odds ratio [OR], 31.53; 95% confidence interval [CI], 10.02-99.19; P < .01; 7 studies). R0 resection rates were significantly higher with ESD (OR, 5.92; 95% CI, 2.75-12.77; P < .01; 8 studies). Curative resection rates tended to be higher with ESD (OR, 3.49; 95% CI, 0.86-14.14; P = .080; 4 studies). There was no significant difference in CRD rates (OR, 0.92; 95% CI, 0.37-2.26; P = .86; 3 studies). Local recurrence rates tended to be lower with ESD (OR, 0.35; 95% CI, 0.11-1.04; P = .058; 10 studies). As for adverse events, there was no significant difference in bleeding, perforation, and postoperative stricture rates. CONCLUSIONS: This systematic review and meta-analysis demonstrates that ESD achieves higher en bloc, R0, and curative resection rates, with a tendency toward lower recurrence rates. These results suggest that ESD may be a more effective option for managing Barrett's neoplasia and EAC. (International Prospective Register of Systematic Reviews [PROSPERO] registration number: CRD42023426486.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Fujiyoshi Y, Khalaf K, He T, et al. Comparison of EMR versus endoscopic submucosal dissection for Barrett's neoplasia and esophageal adenocarcinoma: a systematic review and meta-analysis. Gastrointest Endosc. 2024. PMID: 38879048. doi:10.1016/j.gie.2024.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。